Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 1997

View Archived Issues

Merck & Co. describes avermectin analogue

Thrombin-binding anticoagulant disclosed by Japanese scientists

Fibrinogen receptor antagonists under development at E. Merck

New IL-4 antagonist from Hoechst

Roche describes antiproliferative agents

Merck Frosst discloses leukotriene biosynthesis inhibitors

Chondrex license agreement option exercised

Harvard Scientific to present impotence abstract

Sugen reports efficacy of novel antidiabetic drugs at H&Q conference

Pramlintide can be mixed with insulin

Cortecs launches Helisal One Step test in U.K.

Theratechnologies divests Pharmetics subsidiary

Four HY-TEC autoimmune test kits approved for U.S. marketing

Generic terfenadine approved for U.S. marketing

Antibody-based collaborative agreement reached by CaT and Lilly

Bristol-Myers Squibb/Cadus collaboration extended

Hyal receives notice of allowance for cardiovascular applications of hyaluronic acid

Clinical results with Natrecor in CHF patients reported in Circulation

Panretin phase I/II data described

Elan/Scherer Zydis formulation license agreement

Genetics Institute/Ontogeny functional genomics agreement

Phase I ConXn data reported

SIBIA Neurosciences/Aurora Biosciences drug discovery technology agreement

Antileukemic bisabolane sesquiterpene isolated from natural sources

Genzyme granted U.S. patent for mutation detection technology

Korean researchers report new immunosuppressant from natural source

Genzyme announces launch of instrument line

New manumycin-class antibiotics isolated at Tanabe Seiyaku

Kimmel Cancer Center's immunological disease therapy progress

New analgesic agent described by Japanese academics

Titan in-licenses antipsychotic drug from HMR

SciClone cystic fibrosis drug cleared for clinical testing

RPR seeks FDA approval for Nasacort-HFA

MedCare opens new U.S. treatment centers for urinary incontinence

Sequus' Amphotec earns 19th marketing approval

Access/Strakan license agreement

Labopharm granted US patent on drug delivery system

Further U.S. patent on Celtrix's SomatoKine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...